Your browser doesn't support javascript.
loading
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients.
Vicier, Cecile; Sfumato, Patrick; Isambert, Nicolas; Dalenc, Florence; Robert, Marie; Levy, Christelle; Rezai, Keyvan; Provansal, Magali; Adélaïde, José; Garnier, Séverine; Guille, Arnaud; Carbuccia, Nadine; Popovici, Cornel; Charafe-Jauffret, Emmanuelle; Chaffanet, Max; Birnbaum, Daniel; Pakradouni, Jihane; Bertucci, François; Boher, Jean M; Sabatier, Renaud; Gonçalves, Anthony.
Affiliation
  • Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Sfumato P; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
  • Isambert N; Drug Development Department, Centre Georges François Leclerc, Dijon, France.
  • Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, CRCT, Inserm, Toulouse, France.
  • Robert M; Institut de Cancérologie de l'Ouest-René Gauducheau, Saint-Herblain, France.
  • Levy C; Centre François Baclesse, Department of Medical Oncology, Caen, France.
  • Rezai K; Department of Radio-Pharmacology, Institut Curie, St Cloud, France.
  • Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Adélaïde J; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Garnier S; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Guille A; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Carbuccia N; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France.
  • Charafe-Jauffret E; Aix Marseille University, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Biopathology Department, CRCM, Marseille, France.
  • Chaffanet M; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Birnbaum D; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
  • Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Boher JM; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France; Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France.
  • Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
  • Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France; Predictive Oncology Laboratory, CRCM, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France. Electronic address: goncalvesa@ipc.unicancer.fr.
Eur J Cancer ; 159: 205-214, 2021 12.
Article de En | MEDLINE | ID: mdl-34781168
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Paclitaxel / Antienzymes / Tumeurs du sein triple-négatives Type d'étude: Clinical_trials / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Middle aged Langue: En Journal: Eur J Cancer Année: 2021 Type de document: Article Pays d'affiliation: France
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Paclitaxel / Antienzymes / Tumeurs du sein triple-négatives Type d'étude: Clinical_trials / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Middle aged Langue: En Journal: Eur J Cancer Année: 2021 Type de document: Article Pays d'affiliation: France